|
|
||||||||


,#
* Laboratory of Immunotoxicology,
Section of Dermatology, and
Laboratory of Pathology, Finnish Institute of Occupational Health, Helsinki, Finland;
Department of Dermatology, Heinrich-Heine-University Düsseldorf, Germany;
¶
Institut National de la Santé et de la Recherche Médicale Unité 255, Laboratoire dImmunologie Cellulaire et Clinique, Centre de Recherches Biomedicales des Cordeliers, Paris, France;
||
Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary; and
#
Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland
Patients with atopic dermatitis (AD) have repeated cutaneous exposure to both environmental allergens and superantigen-producing strains of Staphylococcus aureus. We used a murine model of AD to investigate the role of staphylococcal enterotoxin B (SEB) in the modulation of allergen-induced skin inflammation. Mice were topically exposed to SEB, OVA, a combination of OVA and SEB (OVA/SEB), or PBS. Topical SEB and OVA/SEB exposure induced epidermal accumulation of CD8+ T cells and TCRV
8+ cells in contrast to OVA application, which induced a mainly dermal infiltration of CD4+ cells. SEB and OVA/SEB exposure elicited a mixed Th1/Th2-associated cytokine and chemokine expression profile within the skin. Restimulation of lymph node cells from OVA- and OVA/SEB-exposed mice with OVA elicited strong production of IL-13 protein, whereas substantial amounts of IFN-
protein were detected after SEB stimulation of cells derived from SEB- or OVA/SEB-exposed mice. Topical SEB treatment elicited vigorous production of SEB-specific IgE and IgG2a Abs and significantly increased the production of OVA-specific IgE and IgG2a Abs. The present study shows that topical exposure to SEB provokes epidermal accumulation of CD8+ T cells, a mixed Th2/Th1 type dermatitis and vigorous production of specific IgE and IgG2a Abs, which can be related to the chronic phase of atopic skin inflammation.
This article has been cited by other articles:
![]() |
E. Guttman-Yassky, M. A. Lowes, J. Fuentes-Duculan, L. C. Zaba, I. Cardinale, K. E. Nograles, A. Khatcherian, I. Novitskaya, J. A. Carucci, R. Bergman, et al. Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis J. Immunol., November 15, 2008; 181(10): 7420 - 7427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hennino, M. Vocanson, Y. Toussaint, K. Rodet, J. Benetiere, A.-M. Schmitt, M.-F. Aries, F. Berard, A. Rozieres, and J.-F. Nicolas Skin-Infiltrating CD8+ T Cells Initiate Atopic Dermatitis Lesions J. Immunol., May 1, 2007; 178(9): 5571 - 5577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Ardern-Jones, A. P. Black, E. A. Bateman, and G. S. Ogg Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells PNAS, March 27, 2007; 104(13): 5557 - 5562. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |